AbbVie Stock Will $300: Timing and Risks to Watch
AbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Compare tax exposure between dividend ETFs and taxable funds in 2024 to identify the lower-tax option for your goals.
28,172 articlesAbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Investors are focused on a pivotal point in the Iran deal: how verification and enforcement are managed as sanctions ...
SpaceX's hypothetical IPO sent SPCX to the mid-180s, valuing the company near $2.44 trillion. Analysts warn the rally...
Counterfeit money can slip into everyday transactions and end up funding gift cards via fraud. This guide explains th...
A widow spent $1.1 million on cruise-ship art in the years after her husband’s death, shining a light on grief-driven...
Bloom Energy skyrocketed over 248% in the first half of 2026, delivering eye-popping gains for early investors. This ...
BNB Chain announced a new Layer 1 focused on agentic trading, aiming for sub-50ms preconfirmation and no public mempo...
A remote panic in libp2p-gossipsub could crash any Ethereum node with a single message. The vulnerability, CVE-2026-3...
Trust in the FDA is faltering as political pressures collide with science. This piece explains why transparency matte...
Federal investigators say the driver pressed the accelerator to the floor, steering away from the car's auto-drive sy...
A pricing glitch in Moonwell's oracle feed sparked a wave of liquidations, leaving roughly $1.8 million in bad debt. ...
A Life360 board director recently sold several thousand shares after exercising options, timing that coincides with a...